Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

Advances in Enzyme Regulation

Volumn 41, Issue 1, 2001, Pages 221-235

  Johnson, Amy J ^a   Song, Xueqin ^a   Hsu, Ao Lin ^a   Chen, Ching Shih ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ADENOSINE TRIPHOSPHATE; CALCIUM; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DNA FRAGMENT; ENZYME INHIBITOR; ISOENZYME; LACTONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN P53; PROTO ONCOGENE PROTEINS C BCL 2; ROFECOXIB; SULFONAMIDE; THIOPHENE DERIVATIVE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL SURVIVAL; DOSE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MALE; MODEL; NUCLEAR MAGNETIC RESONANCE; PROSTATE CANCER; PROSTATE TUMOR; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TIME;

EID: 0034983860     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(00)00015-7     Document Type: Article

References (31)

1. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I)
2. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)
3. Cyclooxygenase in biology and disease
4. Cancer and arthritis share underlying processes
5. Prostaglandins and cancer
6. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
7. COX-2 and colon cancer
8. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
9. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines, Jpn
10. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
11. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis
12. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes
13. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
14. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
15. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
16. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
17. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
18. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
19. Cox-2 inhibitors
20. Prostate cancer: Clinical and experimental pathology
21. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4
22. 2+ entry mechanism
23. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
24. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
25. PI3K: Downstream AKTion blocks apoptosis
26. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
27. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
28. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
29. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase
30. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
31. Programmed death of nonproliferating androgen-independent prostatic cancer cells